|
|
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials Mohit Bhandari, Jason W. Busse, Dianne Jackowski, Victor M. Montori, Holger Schünemann, Sheila Sprague, Derek Mears, Emil H. Schemitsch, Dianne Heels-Ansdell, and P.J. Devereaux PMCID: PMC332713 Is Cited by the Following Articles in this Archive: No short-cut in assessing trial quality: a case study Karim F Hirji PMCID: PMC2636799 Evolution of the Randomized Controlled Trial in Oncology Over Three Decades Christopher M. Booth, David W. Cescon, Lisa Wang, Ian F. Tannock, and Monika K. Krzyzanowska PMCID: PMC2651075 How good is the orthopaedic literature? Harman Chaudhry, Raman Mundi, Ishu Singh, Thomas A. Einhorn, and Mohit Bhandari PMCID: PMC2759610 Spiralling Medical Costs: Why Canada Needs NICE Medicine Norman J. Temple PMCID: PMC2645173 Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others Lisa Bero, Fieke Oostvogel, Peter Bacchetti, and Kirby Lee PMCID: PMC1885451 Characteristics Associated with Citation Rate of the Medical Literature Abhaya V. Kulkarni, Jason W. Busse, and Iffat Shams PMCID: PMC1852582 Financial conflicts of interest in psychiatry GIOVANNI A FAVA PMCID: PMC1805729 Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals Richelle J Cooper, Malkeet Gupta, Michael S Wilkes, and Jerome R Hoffman PMCID: PMC1924760 Peer-Reviewed Publication of Clinical Trials Completed for Pediatric Exclusivity Daniel Kelly Benjamin, Jr., Philip Brian Smith, M. Dianne Murphy, Rosemary Roberts, Lisa Mathis, Debbie Avant, Robert M Califf, and Jennifer S. Li PMCID: PMC2773660 Published in final edited form as: JAMA. 2006 September 13; 296(10): 1266–1273. doi: 10.1001/jama.296.10.1266. The Tobacco Industry’s Role in the 16 Cities Study of Secondhand Tobacco Smoke: Do the Data Support the Stated Conclusions? Richard L. Barnes, S. Katharine Hammond, and Stanton A. Glantz PMCID: PMC1764165 Readers' and Author's Responses to “Information on Complementary and Alternative Medicine in US Government Databases Is Biased” PMCID: PMC1781330 From optimism to disillusion about commitment to transparency in the medico-industrial complex Iain Chalmers PMCID: PMC1484602 Drug Information Education in Doctor of Pharmacy Programs Fei Wang, William G. Troutman, Teresa Seo, Amy Peak, and Jack M. Rosenberg PMCID: PMC1636960 How NICE may be outflanked R E Ferner and Sarah E McDowell PMCID: PMC1471969 Perspectives on the Efficacy of Antidepressants for Child and Adolescent Depression Amir Raz PMCID: PMC1315362 Research ethics committees: agents of research policy? Elina Hemminki PMCID: PMC1262747 Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution Nandi Siegfried, Mike Clarke, and Jimmy Volmink PMCID: PMC1239977 Early Attempts at Hip Arthroplasty: 1700s to 1950s Pablo F Gomez and Jose A Morcuende PMCID: PMC1888777 The Commercialisation of Medical and Scientific Reporting Timothy Caulfield PMCID: PMC539042 Tracking system for studies should be in place J A C Delaney PMCID: PMC478277 SSRI treatment for under-18s Mark A. Voysey PMCID: PMC419742 SSRI treatment for under-18s Mohit Bhandari, Victor M. Montori, and P.J. Devereaux PMCID: PMC419743 Randomized clinical trials: What gets published, and when? Laurence Hirsch PMCID: PMC332714
|
